Cargando…
Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET
BACKGROUND: Obesity has been identified as a risk factor for cognitive decline and Alzheimer’s disease (AD). The aim of this study was to investigate the effect of obesity on neuroinflammation and cerebral glucose metabolism using PET in a mouse model of β-amyloidosis and determine the relationship...
Autores principales: | Barron, Anna M., Tokunaga, Masaki, Zhang, Ming-Rong, Ji, Bin, Suhara, Tetsuya, Higuchi, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006247/ https://www.ncbi.nlm.nih.gov/pubmed/27578213 http://dx.doi.org/10.1186/s12974-016-0700-x |
Ejemplares similares
-
Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy
por: Fairley, Lauren H., et al.
Publicado: (2021) -
A Small-Animal Pharmacokinetic/Pharmacodynamic PET Study of Central Serotonin 1A Receptor Occupancy by a Potential Therapeutic Agent for Overactive Bladder
por: Nakatani, Yosuke, et al.
Publicado: (2013) -
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
por: Savonenko, Alena V., et al.
Publicado: (2015) -
Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H(3) receptors
por: Koga, Kazumi, et al.
Publicado: (2016) -
Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [(11)C]PBB3-PET study
por: Shimada, Hitoshi, et al.
Publicado: (2016)